Scholars Central

Conference abstract

How to select therapeutic criteria for nanomedicines to treat cancer?

Authors: Ljubimova J Y

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Traditional chemotherapy is being gradually complemented or replaced with targeted molecular therapeutics since the discovery of molecular heterogeneity of tumors with similar histology. Among modern drug formulations, nanodrugs are highly promising vehicles for multi-targeting and can provide molecular combination therapy and thus, personalized therapies designed to treat individual tumors with specific marker expression profiles. Nanomedicines are able to block cancerspecific proteins much more effectively; nano drug targetability may decrease general toxicity in comparison with classical chemotherapeutic drugs; novel horizons are opened in imaging and diagnostics by using nano imaging agents. However, a variety of problems concerning the nano drug safety in terms of toxicity, reproducibility of production, compositions, size, and polydispersity are slowing down their application for the IND submission and FDA approval. This talk will present the overview with examples of current nanodrugs? pharmaceutical problems and possible solutions for the design of novel nano therapeutics and nano imaging agents for experimental validation and future clinical applications.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nanomedicine & Nanotechnology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanomedicine & Nanotechnology
  • SubjectNanotechnology
  • BylineArticles whose byline prints “Ljubimova J Y”